CWIR: THE AUTHORIZED SHARES 21 BILLION PLUS 11 BILLION....????? Check it out....
On April 18, 2007, the Board of Directors of the Company (the “ Board of Directors ”) and the stockholders of the Company holding a majority of the outstanding shares of common stock of the Company approved an amendment to the Articles of Incorporation to increase the authorized Common Stock from 2,000,000,000 to 20,000,000,000 shares. The text of the Amended and Restated Articles of Incorporation is attached hereto as Appendix A.
CWIR: RATIFICATION OF SHARE EXCHANGE AGREEMENT
READ THIS...AND according to GRANDE that SUMMIT DEAL DID GO THROUGH....SO IT WOULD SEEM TO BE THE SAME FOR THE CWIR SHARES!!!
The Board of Directors and the stockholders of the company have approved that certain share exchange, entered into by the Company on April 17, 2007, with Summit Medical Technologies, Inc., a New Hampshire corporation (“Summit”), pursuant to which Summit transferred to the Company 19,500,160 shares of Summit common stock, no par value per share (“Common Stock”), and the Company transferred to Summit 100 shares of the Company’s Series A Preferred Stock, par value $0.01 per share (the “Exchange Agreement”). The Company’s Series A Preferred Stock is convertible into an aggregate of 11,073,757,200 shares of the Company’s common stock, $.001 par value per share, upon the twentieth (20 th ) day after the mailing of a Definitive Schedule 14C Information Statement to the Central shareholders pursuant to the terms and conditions set forth in the Exchange Agreement. The Exchange Agreement contains various representations, warranties, covenants and agreements, and indemnity obligations of the parties.
Summit Medical Technologies is a medical sales and distribution company focusing in the safety and intravenous therapy markets.
News 
Market Data 
Discover 
AI
